If estrogen therapy is begun prior to pelvis ossification, which occurs around the age of 25, the pelvic outlet and inlet open slightly. Table 1 Testosterone options for transgender men. Long-term evaluation of cross-sex hormone treatment in transsexual persons. The main effects of hormone therapy in transgender women are feminization and demasculinizationand are as follows:. Am J Public Health ; Alfatradiol Dutasteride Epristeride Finasteride Saw palmetto extract. Hip discomfort is common.
Vemer 15 December
Allylestrenol Altrenogest Dienogest Etynodiol diacetate Lynestrenol Norethisterone norethindrone Norethisterone acetate Norethisterone enanthate Noretynodrel Norgesterone Norgestrienone Normethandrone methylestrenolone Norvinisterone Oxendolone Quingestanol acetate Tibolone ; Gonanes: To avoid excess risk, the goal is to maintain hormone levels in the normal range for the target gender. A Systematic Review and Metaanalysis".
However, alkaline phosphatase, potassium, and creatinine levels were similar to male reference levels.